Table 1 Baseline and demographic data. Data are expressed as percentage (frequency) or median (IQR)
Ticagrelor (n = 142) | Clopidogrel (n = 259) | p | |
|---|---|---|---|
Age (years) | 66 (56–73) | 67 (56–67) | 0.206 |
Age ≥ 75 years | 21.8 (31) | 32.0 (83) | 0.037 |
Sex male | 73.9 (105) | 69.9 (81) | 0.420 |
BMI (kg/m2)a | 26 (24–30) | 26 (24–29) | 0.772 |
Hypertension | 52.8 (75) | 56.0 (145) | 0.600 |
Dyslipidemia | 36.6 (52) | 39.0 (101) | 0.668 |
Active smoke | 45.8 (65) | 37.8 (98) | 0.137 |
Diabetes mellitus | 22.5 (32) | 18.5 (48) | 0.362 |
Familiar of CAD | 21.1 (30) | 24.7 (64) | 0.461 |
Previous stable angina | 11.3 (16) | 6.6 (17) | 0.128 |
Previous unstable angina | 3.5 (5) | 4.6 (12) | 0.797 |
Previous AMI | 11.3 (16) | 11.2 (29) | 1.000 |
Previous PCI | 7.0 (10) | 9.3 (24) | 0.574 |
Previous CABG | 1.4 (2) | 0.0 (0) | 0.125 |
Previous CVA | 4.9 (7) | 7.3 (19) | 0.403 |
PVD | 16.2 (23) | 11.2 (29) | 0.164 |
Chronic kidney disease | 7.0 (10) | 4.6 (12) | 0.361 |
COPD | 8.5 (12) | 8.9 (23) | 1.000 |
Previous bleeding | 0.7 (1) | 3.9 (10) | 0.106 |
Previous neoplasia | 10.6 (15) | 15.8 (41) | 0.175 |